Research Acceleration Programme
The RAP is a contestable acceleration programme for very early-stage medical device and digital health technology projects working towards clinical application and commercialisation.
This programme will identify, de-risk and curate opportunities for innovative health technologies, with an emphasis towards those addressing accessibility and inequity issues. The objective is to create a high-value deep tech pipeline for the investment community.
This initiative is funded by MBIE for $2.7 million per year for 3 years (2022 - 2024) and hosted by the University of Auckland on behalf of the CMDT partners.
Request for proposals
Te Tītoki Mataora is excited to partner with Te Whatu Ora and Whānau Tahi to launch the Medtech-iQ Aotearoa Healthtech Challenge. Alongside our usual request for medical and health technology proposals, we are seeking RAP Stages I, II and III proposals that address the three priority areas identified by our partners. These areas are purposely broad to capture the range of possible solution concepts. The normal guidelines to RAP proposals apply. The Challenge is open for the next three RAP Stage II RfP rounds between August 2023 – July 2024.
Medtech-iQ Aotearoa Healthtech Challenge
Long-term conditions pathway (Te Whatu Ora Priority): Innovative solutions that address any stage along the pathway of long-term condition development, from early prevention through to enhanced care – for example, from early prevention of diabetes through to chronic kidney disease and transplant – that improve patients’ health or quality of life and/or minimise health system burden.
Virtual/Digital Hospital (Te Whatu Ora Priority): Any technology solutions that will help move and support healthcare into the community.
Whānau supporting Whānau (Whānau Ora Priority): Technology solutions that empower whānau to support each other in the prevention, diagnosis and management of COPD, Cardiovascular disease or Diabetes in their homes and communities.
$10K - $20K
$40K - $80K
PROOF OF CONCEPT
FUNDING AVAILABLE PER PROJECT:
COLLABORATION & IDEATION
SCALE-UP FUNDING & SUPPORT
Collaboration & Ideation
Stage 1 RAP funding supports the formation of new collaborative relationships between researchers, clinicians, companies and/or partnerships with Māori and Pacific communities.
This is an open call for proposals and submission can be made at any time. Proposals are reviewed every two months and awarded within 2 weeks.
$10k - $20k
Stage II RAP funding identifies concepts with the potential to be viable for clinical application and commercialisation.
In 2024, there are calls for proposals (RfP) in January, May, and August. These will be awarded in April, August, and November respectively.
$40k - $80k
Stage III RAP acceleration funding is to support projects to refine proven concept and prototypes including small scale clinical trials and preparation for commercial readiness.
Applications for this fund are by invitation. There is an interview process prior to submission of a proposal. In 2024, awards will be made in April, August, and November.
Do I have to complete the entire RAP funding pathway?
You can enter the pathway either at Stage I or Stage II, however, to apply for Stage III funding you must have successfully completed Stage II.
Can I apply for seed funding more than once?
Yes, you can apply for Stage I and II funding more than once, however, it would require a strategy as to why you are coming back a second time, particularly for Stage II.
How many collaborations are required for this programme?
For Stage I and Stage II funding, you must have a collaboration of at least 2 organisations with one of them being a member of the CMDT.
For Stage III, a single organisation can apply alone.
Can I bring international collaborators?
Yes, we do encourage international collaboration. Your international collaborators will need to bring their own funding to support their side of the project.